73

Oncology
Prevention and treatment of tumors, and caring for cancer patients.
Sub Categories on Oncology
Latest Articles
Patient's own immune cells effective as living medicine for melanoma

Patient's own immune cells effective as living medicine for melanoma

byNetherlands Cancer InstitutePreparing tumor-infiltrating lymphocyte therapy for melanoma patients in the lab. Credit: NKIA patient's own immune cells, multiplied into an army of billions o

Patient's own immune cells effective as living medicine for melanoma

byNetherlands Cancer InstitutePreparing tumor-infiltrating lymphocyte therapy for melanoma patients in the lab. Credit: NKIA patient's own immune cells, multiplied into an army of billions o
Frontline Immunotherapy, Delayed Nephrectomy May Allow for Improved Disease Control in mRCC

Frontline Immunotherapy, Delayed Nephrectomy May Allow for Improved Disease Control in mRCC

July 14, 2023Caroline SeymourNeoadjuvant immunotherapy–based combinations led to reductions in tumor size and pathologic necrosis at the time of cytoreductive nephrectomy in patients with metastatic r

Frontline Immunotherapy, Delayed Nephrectomy May Allow for Improved Disease Control in mRCC

July 14, 2023Caroline SeymourNeoadjuvant immunotherapy–based combinations led to reductions in tumor size and pathologic necrosis at the time of cytoreductive nephrectomy in patients with metastatic r
Molecular map reveals insights into the genetic drivers of chronic lymphocytic leukemia

Molecular map reveals insights into the genetic drivers of chronic lymphocytic leukemia

byMassachusetts General HospitalCredit: Unsplash/CC0 Public DomainA newly constructed map of the landscape of genetic changes in chronic lymphocytic leukemia (CLL), a type of cancer of the blood

Molecular map reveals insights into the genetic drivers of chronic lymphocytic leukemia

byMassachusetts General HospitalCredit: Unsplash/CC0 Public DomainA newly constructed map of the landscape of genetic changes in chronic lymphocytic leukemia (CLL), a type of cancer of the blood
PD-1/VEGFR-2 Inhibitor Combo Shows Durable Responses in Nasopharyngeal Carcinoma

PD-1/VEGFR-2 Inhibitor Combo Shows Durable Responses in Nasopharyngeal Carcinoma

February 10, 2023Ashling WahnerThe combination of camrelizumab and apatinib led to long-term antitumor activity with manageable toxicities in patients with recurrent or metastatic nasopharyngeal carci

PD-1/VEGFR-2 Inhibitor Combo Shows Durable Responses in Nasopharyngeal Carcinoma

February 10, 2023Ashling WahnerThe combination of camrelizumab and apatinib led to long-term antitumor activity with manageable toxicities in patients with recurrent or metastatic nasopharyngeal carci
Study identifies skin microbiome as a factor in stem cell transplants

Study identifies skin microbiome as a factor in stem cell transplants

Study identifies skin microbiome as a factor in stem cell transplantsbyMedical University of ViennaCredit: AI-generated imageOrgan damage occurs in up to 70% of patients in the first few months

Study identifies skin microbiome as a factor in stem cell transplants

Study identifies skin microbiome as a factor in stem cell transplantsbyMedical University of ViennaCredit: AI-generated imageOrgan damage occurs in up to 70% of patients in the first few months
Ultrasound-guided surgery could be quicker, less painful and more effective for treating early form of breast cancer

Ultrasound-guided surgery could be quicker, less painful and more effective for treating early form of breast cancer

by European Organisation for Research and Treatment of CancerAntonio Esgueva using IOUS to guide breast surgery. Credit: Antonio Esguega / EORTCUsing ultrasound to guide surgery for patients with duct

Ultrasound-guided surgery could be quicker, less painful and more effective for treating early form of breast cancer

by European Organisation for Research and Treatment of CancerAntonio Esgueva using IOUS to guide breast surgery. Credit: Antonio Esguega / EORTCUsing ultrasound to guide surgery for patients with duct
Study shows giving entire course of radiation treatment in less than a second is feasible

Study shows giving entire course of radiation treatment in less than a second is feasible

byPerelman School of Medicine at the University of PennsylvaniaCancer patients may one day be able to get their entire course of radiation therapy in less than a second rather than coming in for

Study shows giving entire course of radiation treatment in less than a second is feasible

byPerelman School of Medicine at the University of PennsylvaniaCancer patients may one day be able to get their entire course of radiation therapy in less than a second rather than coming in for
Discovery explains cancer chemotherapy resistance, offers solution

Discovery explains cancer chemotherapy resistance, offers solution

byCornell UniversityGraphical abstract. Credit:Molecular Cell(2022). DOI: 10.1016/j.molcel.2022.08.028Researchers have uncovered a novel pathway that explains how cancer cells become

Discovery explains cancer chemotherapy resistance, offers solution

byCornell UniversityGraphical abstract. Credit:Molecular Cell(2022). DOI: 10.1016/j.molcel.2022.08.028Researchers have uncovered a novel pathway that explains how cancer cells become
New factor in the development of hereditary kidney cancer discovered

New factor in the development of hereditary kidney cancer discovered

by Gabriele Meseg-Rutzen,University of CologneHira-andFh1-deficient cells promote tumor initiation, growth, and invasion in vivo.(A) Scheme of xenograft injections in the flank of nu

New factor in the development of hereditary kidney cancer discovered

by Gabriele Meseg-Rutzen,University of CologneHira-andFh1-deficient cells promote tumor initiation, growth, and invasion in vivo.(A) Scheme of xenograft injections in the flank of nu
P53 could be key to therapies for salivary gland cancer

P53 could be key to therapies for salivary gland cancer

Mouse models show that activating a non-mutated form of the gene could lead to developing therapies for salivary gland cancer.Researchers at the University of Michigan Rogel Cancer Center and School o

P53 could be key to therapies for salivary gland cancer

Mouse models show that activating a non-mutated form of the gene could lead to developing therapies for salivary gland cancer.Researchers at the University of Michigan Rogel Cancer Center and School o
Researchers identify new therapeutic target for colorectal cancer

Researchers identify new therapeutic target for colorectal cancer

byRockefeller University PressCancer—Histopathologic image of colonic carcinoid. Credit: Wikipedia/CC BY-SA 3.0Researchers at the University of Toronto have identified a key protein that support

Researchers identify new therapeutic target for colorectal cancer

byRockefeller University PressCancer—Histopathologic image of colonic carcinoid. Credit: Wikipedia/CC BY-SA 3.0Researchers at the University of Toronto have identified a key protein that support
New tool gives deeper understanding of glioblastoma

New tool gives deeper understanding of glioblastoma

byCornell UniversityGlioblastoma (histology slide). Credit: Wikipedia/CC BY-SA 3.0Researchers in the lab of Charles Danko at the Baker Institute for Animal Health have developed a new tool to st

New tool gives deeper understanding of glioblastoma

byCornell UniversityGlioblastoma (histology slide). Credit: Wikipedia/CC BY-SA 3.0Researchers in the lab of Charles Danko at the Baker Institute for Animal Health have developed a new tool to st